When was Trimtech Therapeutics founded?

Trimtech Therapeutics was founded in 2023 and raised its 1st funding round 2 years after it was founded.

Where is Trimtech Therapeutics located?

Trimtech Therapeutics is headquartered in Cambridge, United Kingdom.

How many employees does Trimtech Therapeutics have?

As of May 31, 2026, the latest employee count at Trimtech Therapeutics is 21.

Is Trimtech Therapeutics a funded company?

Trimtech Therapeutics is a funded company, having raised a total of $47M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 05, 2025.

When was the latest funding round of Trimtech Therapeutics?

Trimtech Therapeutics' latest funding was a $***** Seed round on Jun 23, 2026, with participation from 10 investors.

Where does Trimtech Therapeutics rank among its competitors?

Trimtech Therapeutics ranks 255th amongst 3096 active competitors, of which 1074 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Trimtech Therapeutics?

Trimtech Therapeutics' top competitors include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Among them, Trimtech Therapeutics secured the most recent funding round in June, 2026.

Trimtech Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Company Details

They develop treatments for CNS and inflammatory disorders. The company creates highly specific degraders that selectively target and remove toxic proteins. This approach is based on research into TRIM21, a ubiquitin ligase, to treat protein aggregation disorders. They aim to provide therapeutic benefits for intractable CNS and inflammatory diseases.

Website: trimtechtherapeutics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2023

Location

Cambridge, United Kingdom

Stage

Seed

Total Funding

$47M in 2 rounds

Latest Funding Round

Seed, Jun 23, 2026, $*****

Investors

SV Health Investors & 7 more

Ranked

255^th among 3096 active competitors

Employee Count

21 as on May 31, 2026

Similar Companies

Jazz Pharmaceuticals & 919 more

View Trimtech Therapeutics' full profile

Trimtech Therapeutics has raised a total funding of $47M over 2 rounds. Its first funding round was on Mar 05, 2025. Its latest funding round was a Seed round on Jun 23, 2026 for $*****. 10 investors participated in its latest round. Trimtech Therapeutics has 8 institutional investors.

Here is the list of recent funding rounds of Trimtech Therapeutics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 23, 2026	9195590	Seed	9434894	7134209	8982280	2825178
Mar 05, 2025	5853856	Seed	8640629	8794769	Cambridge Innovation Capital & 1 more	M Ventures & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Trimtech Therapeutics's funding rounds and investors

The founders of Trimtech Therapeutics are Damian Crowther, Leo James and William McEwan.

Here are the details of Trimtech Therapeutics' key team members:

Damian Crowther: Former Co-Founder of Trimtech Therapeutics.
Leo James: Co-Founder of Trimtech Therapeutics.
William McEwan: Co-Founder of Trimtech Therapeutics.

View details of Trimtech Therapeutics's Founder profiles and Board Members

Trimtech Therapeutics' employee count trend

Trimtech Therapeutics has 21 employees as of May 26. Here is Trimtech Therapeutics's employee count trend over the years:

Employee count trend for Trimtech Therapeutics

Uncover Trimtech Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Trimtech Therapeutics include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Here is the list of Top 10 competitors of Trimtech Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Digital Pharma Lab & 11 others	78/100
3rd	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 28 others	77/100
4th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
5th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
6th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
9th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
10th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, Khosla Ventures & 23 others	71/100
255th	Trimtech Therapeutics 2023, Cambridge (United Kingdom), Seed	They develop treatments for CNS and inflammatory disorders	$47M	Lilly, University of Cambridge & 6 others	60/100